Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$33.40
0.230.69%
At close: -
$33.40
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Legend Biotech Analyst Ratings and Price Targets | NASDAQ:LEGN | Benzinga
Legend Biotech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Legend Biotech Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
HC Wainwright & Co.
Morgan Stanley
Piper Sandler
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Legend Biotech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/22/2025 | Buy Now | — | RBC Capital | Brian Abrahams49% | $84 → $84 | Reiterates | Outperform → Outperform | Get Alert |
| 04/16/2025 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 04/08/2025 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 03/17/2025 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $82 → $80 | Maintains | Overweight | Get Alert |
| 03/12/2025 | Buy Now | — | Guggenheim | Michael Schmidt57% | — | Reiterates | Neutral → Neutral | Get Alert |
| 03/12/2025 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $75 | Maintains | Buy | Get Alert |
| 01/23/2025 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 01/21/2025 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 12/30/2024 | Buy Now | — | Piper Sandler | Edward Tenthoff52% | $78 → $78 | Reiterates | Overweight → Overweight | Get Alert |
| 12/10/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 12/09/2024 | Buy Now | — | Cantor Fitzgerald | Rick Bienkowski27% | $83 → $83 | Reiterates | Overweight → Overweight | Get Alert |
| 12/09/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 10/29/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 10/16/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 10/08/2024 | Buy Now | — | Redburn Atlantic | Qize Ding4% | → $86 | Initiates | → Buy | Get Alert |
| 10/04/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 09/30/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 09/27/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/28/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 08/12/2024 | Buy Now | — | Scotiabank | George Farmer42% | $70 → $76 | Maintains | Sector Outperform | Get Alert |
| 08/12/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 07/18/2024 | Buy Now | — | Scotiabank | George Farmer42% | $65 → $70 | Maintains | Sector Outperform | Get Alert |
| 07/18/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 07/15/2024 | Buy Now | — | TD Cowen | Yaron Werber36% | $71 → $67 | Maintains | Buy | Get Alert |
| 07/03/2024 | Buy Now | — | BMO Capital | Kostas Biliouris33% | $90 → $90 | Maintains | Outperform | Get Alert |
| 07/03/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $86 → $86 | Reiterates | Outperform → Outperform | Get Alert |
| 06/17/2024 | Buy Now | — | Piper Sandler | Edward Tenthoff52% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | — | Truist Securities | Asthika Goonewardene41% | → $88 | Initiates | → Buy | Get Alert |
| 06/06/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $73 → $73 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $86 → $73 | Maintains | Buy | Get Alert |
| 05/23/2024 | Buy Now | — | Deutsche Bank | James Shin37% | → $60 | Initiates | → Buy | Get Alert |
| 05/14/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $85 → $86 | Maintains | Outperform | Get Alert |
| 05/14/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $87 → $86 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 04/23/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2024 | Buy Now | — | Scotiabank | George Farmer42% | $65 → $65 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 04/16/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | Buy Now | — | Cantor Fitzgerald | Rick Bienkowski27% | → $82 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | Buy Now | — | UBS | Ashwani Verma43% | $76 → $81 | Maintains | Buy | Get Alert |
| 03/13/2024 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | Buy Now | — | Raymond James | Sean McCutcheon12% | → $86 | Initiates | → Outperform | Get Alert |
| 03/12/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 03/08/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 03/07/2024 | Buy Now | — | RBC Capital | Leonid Timashev40% | $85 → $85 | Reiterates | Outperform → Outperform | Get Alert |
| 01/24/2024 | Buy Now | — | Barclays | Gena Wang50% | $93 → $94 | Maintains | Overweight | Get Alert |
| 12/22/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
| 12/19/2023 | Buy Now | — | Scotiabank | George Farmer42% | → $65 | Initiates | → Sector Perform | Get Alert |
| 11/15/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $86 → $87 | Maintains | Buy | Get Alert |
| 10/18/2023 | Buy Now | — | Barclays | Gena Wang50% | $92 → $93 | Maintains | Overweight | Get Alert |
| 10/18/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $85 → $86 | Maintains | Buy | Get Alert |
| 08/16/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | → $85 | Reiterates | Buy → Buy | Get Alert |
| 07/21/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $82 → $85 | Maintains | Buy | Get Alert |
| 07/21/2023 | Buy Now | — | Barclays | Gena Wang50% | $90 → $92 | Maintains | Overweight | Get Alert |
| 07/20/2023 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $65 → $85 | Maintains | Overweight | Get Alert |
| 06/16/2023 | Buy Now | — | RBC Capital | Leonid Timashev40% | → $83 | Reiterates | Outperform → Outperform | Get Alert |
| 06/13/2023 | Buy Now | — | BTIG | Justin Zelin41% | $85 → $90 | Maintains | Buy | Get Alert |
| 06/08/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | → $82 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $77 → $82 | Maintains | Buy | Get Alert |
| 05/25/2023 | Buy Now | — | William Blair | Sami Corwin11% | — | Initiates | → Market Perform | Get Alert |
| 05/22/2023 | Buy Now | — | Daiwa Capital | Wilfred Yuen3% | — | Initiates | → Buy | Get Alert |
| 05/22/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | → $77 | Reiterates | Buy → Buy | Get Alert |
| 05/19/2023 | Buy Now | — | RBC Capital | Leonid Timashev40% | $74 → $83 | Maintains | Outperform | Get Alert |
| 05/19/2023 | Buy Now | — | Barclays | Gena Wang50% | $65 → $90 | Maintains | Overweight | Get Alert |
| 04/25/2023 | Buy Now | — | BMO Capital | Kostas Biliouris33% | $79 → $90 | Maintains | Outperform | Get Alert |
| 04/20/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | $66 → $77 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | — | BTIG | Justin Zelin41% | $75 → $85 | Maintains | Buy | Get Alert |
| 04/19/2023 | Buy Now | — | JP Morgan | Jessica Fye67% | $65 → $76 | Maintains | Overweight | Get Alert |
| 04/18/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | → $66 | Reiterates | → Buy | Get Alert |
| 04/12/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | → $66 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | → $66 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | Buy Now | — | HC Wainwright & Co. | Mitchell Kapoor45% | → $66 | Initiates | → Buy | Get Alert |
| 03/24/2023 | Buy Now | — | RBC Capital | Leonid Timashev40% | → $73 | Initiates | → Outperform | Get Alert |
| 01/25/2023 | Buy Now | — | Barclays | Gena Wang50% | $53 → $65 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $60 → $65 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | — | Piper Sandler | Edward Tenthoff52% | $72 → $78 | Maintains | Overweight | Get Alert |
| 12/06/2022 | Buy Now | — | JP Morgan | Jessica Fye67% | $61 → $65 | Maintains | Overweight | Get Alert |
| 12/06/2022 | Buy Now | — | UBS | Ashwani Verma43% | → $66 | Initiates | → Buy | Get Alert |
| 11/02/2022 | Buy Now | — | Evercore ISI Group | Umer Raffat43% | — | Initiates | → Outperform | Get Alert |
| 11/01/2022 | Buy Now | — | Cowen & Co. | Yaron Werber36% | — | Initiates | → Outperform | Get Alert |
| 10/31/2022 | Buy Now | — | Guggenheim | Kelsey Goodwin36% | — | Initiates | → Neutral | Get Alert |
| 10/13/2022 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $63 → $60 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $55 → $63 | Maintains | Overweight | Get Alert |
| 06/17/2022 | Buy Now | — | BMO Capital | Kostas Biliouris33% | → $77 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Legend Biotech (LEGN) stock?
The latest price target for Legend Biotech (NASDAQ:LEGN) was reported by RBC Capital on April 22, 2025. The analyst firm set a price target for $84.00 expecting LEGN to rise to within 12 months (a possible 151.50% upside). 38 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Legend Biotech (LEGN)?
The latest analyst rating for Legend Biotech (NASDAQ:LEGN) was provided by RBC Capital, and Legend Biotech reiterated their outperform rating.
When was the last upgrade for Legend Biotech (LEGN)?
The last upgrade for Legend Biotech Corp happened on April 17, 2024 when Scotiabank raised their price target to $65. Scotiabank previously had a sector perform for Legend Biotech Corp.
When was the last downgrade for Legend Biotech (LEGN)?
There is no last downgrade for Legend Biotech.
When is the next analyst rating going to be posted or updated for Legend Biotech (LEGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Legend Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Legend Biotech was filed on April 22, 2025 so you should expect the next rating to be made available sometime around April 22, 2026.
Is the Analyst Rating Legend Biotech (LEGN) correct?
While ratings are subjective and will change, the latest Legend Biotech (LEGN) rating was a reiterated with a price target of $84.00 to $84.00. The current price Legend Biotech (LEGN) is trading at is $33.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
